Kv1.3 potassium channel antagonists

EP4747235A1Pending Publication Date: 2026-05-27MUNA THERAPEUTICS APS

View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office: EP · EP
Patent Type: Applications
Current Assignee / Owner: MUNA THERAPEUTICS APS
Filing Date: 2024-07-18
Publication Date: 2026-05-27

Application Information

Patent Timeline

18 Jul 2024

Application

27 May 2026

Publication

EP4747235A1

IPC: C07D209/42; C07D401/06; C07D403/06; C07D403/14; C07D405/06; C07D487/10; A61P25/28; A61K31/404; A61K31/4965; A61K31/4985; A61K31/5355; A61P5/00; A61P9/00; A61P25/00; A61P35/00; A61P37/00; C07D403/12; C07D405/14; C07D413/06; C07D487/04; C07D498/04

CPC: A61P25/28; C07D209/42; C07D401/06; C07D403/06; C07D403/14; C07D405/06; C07D487/10; A61P5/00

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗

Get free access to AI patent search and analysis

Check patentability, review prior art and ask IP Agent with full patent context.

Smart Images

Figure IMGF000003_0001
Figure IMGF000004_0001
Figure IMGF000008_0001

Patent Text Reader

Abstract

The present invention relates to KV1.3 potassium channel antagonists and their use in the treatment and management of inflammatory diseases, including neuroinflammatory diseases.

Need to check novelty before this filing date? Find Prior Art